Coronavirus live updates: Summer air travel down 76%, drugmakers pledge to prioritize vaccine safety

Nine drugmakers working on coronavirus vaccines publicly pledged on Tuesday to prioritize safety and uphold rigorous scientific standards as concerns mount of political pressure to bring a vaccine to market before the Nov. 3 U.S. presidential election. The pledge sought to “ensure public confidence” by committing to only apply for regulatory authorization when enough data has been collected from a large phase three trial. Three vaccine manufacturers have now entered phase three trials. 

Here are some of the biggest developments Tuesday:

The following data was compiled by Johns Hopkins University:

• Global cases: More than 27.3 million
• Global deaths: At least 893,200
• U.S. cases: More than 6.30 million
• U.S. deaths: At least 189,200